Ignite Creation Date:
2025-12-25 @ 1:20 AM
Ignite Modification Date:
2026-02-22 @ 7:18 AM
Study NCT ID:
NCT02284893
Status:
COMPLETED
Last Update Posted:
2018-06-01
First Post:
2014-11-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-09-09
Start Date Type:
ACTUAL
Primary Completion Date:
2016-09-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-09-20
Completion Date Type:
ACTUAL
First Submit Date:
2014-11-04
First Submit QC Date:
None
Study First Post Date:
2014-11-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-09-18
Results First Submit QC Date:
None
Results First Post Date:
2018-06-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-05-29
Last Update Post Date:
2018-06-01
Last Update Post Date Type:
ACTUAL